Enliven Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $878k | 17k | 50.75 |